Services in many aspects of life are becoming virtual; shops, utility bills and even the faithful paperback book have now become digitised, with an increasing number of us adopting these new formats due to the convenience and cost savings they offer. In the last decade, healthcare spending in the OECD has increased from an average…
Taking a flippant (and heavily biased) approach, bad writing can be categorised by the (suspected) attitude or underlying motivation of the protagonist, who in this case is convinced that their writing rivals that of Shakespeare for poetry with a dash of JK Rowling for universal appeal. However, there are a number of different reasons for the type of writing they produce.
Those of you know me well (including those who wish they didn’t) will know that my heart and roots belong in New Zealand. Fortified by a large quantity of excellent Sauvignon Blanc from that distant shore, naturally the next zoo creature that personified a medical writing style (or lack thereof) had to fit in with…
The primary reason for performing health economics and outcomes research (HEOR) is to inform decisions – whether those decisions are about more research, or the use or value of a product or service. The key concept is that of INFORMING. If you are not communicating the results of your research adequately, it doesn’t matter how good it is – it won’t be fulfilling its primary function.
For most researchers, the manuscript submission process is fraught with more questions than answers. Christine Laine, MD, MPH, senior deputy editor of the Annals of Internal Medicine talks about what journal editors expect from health economists.
The healthcare reform bill was only passed at the end of March but its effects are already being reported by some of the biggest players in the pharmaceutical industry
Comparative effectiveness has really come to the fore following the Healthcare Reform Bill and has the potential to seriously affect businesses in the healthcare industry. But is it all just a misunderstood can of worms?
The UK National Institute for Health and Clinical Excellence (NICE) has overhauled its technology appeals process with the aim of making it quicker and slicker. Despite the efforts at greater clarity, the short period for appealing final decisions remains, so time is of the essence.
Updated guidance on the appeals process for technology appraisals doesn’t exactly conjure up sexy headlines, but the process affects everyone – manufacturer, provider, and patient – so it’s worth the read.
Structural intervention may be what’s needed to tackle chronic health problems. But big ideas prompt big questions, including: How much will this cost? Who will pay for it? And how do we get ‘buy-in’?